The detection of diseases at an early stage of development provides many benefits, such as timely and specific treatment with considerable cost savings and the ability to trace the cause of an illness. To support the progress of early diagnostics, VITO focuses on the development of diagnostic assays and technologies, and on the identification of new biomarkers. We do this in close collaboration with academic partners, health experts and the pharmaceutical and biotech industries.

Publications

Alternative indications for corneal crosslinking
Year: 
2021
Journal: 
JOURNAL OF CATARACT AND REFRACTIVE SURGERY
Van Tigchelt, L; Van Eijgen, J; Delbeke, H
The peppermint breath test benchmark for PTR-MS and SIFT-MS
Year: 
2021
Journal: 
JOURNAL OF BREATH RESEARCH
Henderson, B; Slingers, G; Pedrotti, M; Pugliese, G; Malaskova, M; Bryant, L; Lomonaco, T; Ghimenti, S; Moreno, S; Cordell, R; Harren, FJM; Schubert, J; Mayhew, CA; Wilde, M; Di Francesco, F; Koppen, G; Beauchamp, JD; Cristescu, SM
Towards Building a Quantitative Proteomics Toolbox in Precision Medicine: A Mini-Review
Year: 
2021
Journal: 
FRONTIERS IN PHYSIOLOGY
Rojo, AC; Heylen, D; Aerts, J; Thas, O; Hooyberghs, J; Ertaylan, G; Valkenborg, D
Comparative retinal imaging in mouse models of proteinopathies identifies disease specific biomarkers
Year: 
2021
Journal: 
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
De Groef, L; Veys, L; Vandenabeele, M; Hadoux, X; Lemmens, S; Serneels, L; Theunis, J; De Strooper, B; Stalmans, I; van Wijngaarden, P; Moons, LKM
Retinal Vascular Metrics Predict Pial Collateral Status in Patients With Acute Ischemic Stroke
Year: 
2021
Journal: 
STROKE
Adnan, K; Saadat, K; Boever, PD; Nele, G; Maher, S; Petropoulos, IN; Georgios, P; Naveed, A; Ashfaq, S; Rayaz, M

Pages